Director, HTA, Value & Evidence (HV&E), I&I / Brepocitinib (Med Rheum)
The Director, Value & Evidence – Brepocitinib will support the strategic goals of the Inflammation & Immunology Business Unit by driving optimal launch and patient access for Brepocitinib through the generation, integration, and translation of robust value and evidence.This role...